Written answers
Thursday, 9 November 2017
Department of Health
Medicinal Products Availability
Carol Nolan (Offaly, Sinn Fein)
Link to this: Individually | In context | Oireachtas source
197. To ask the Minister for Health further to Parliamentary Question No. 951 of 26 July 2017, the status of the provision of the drug Spinraza to persons with muscular atrophy; and if he will make a statement on the matter. [47520/17]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicines under the community drug schemes, in accordance with the provisions of the Health (Pricing and Supply of Medical Goods) Act 2013; therefore, the matter has been referred to the HSE for reply to the Deputy.
No comments